Search results for: 'Colocation Data Center Service Trends'

The global approach to sustainability and circular economies hinges on increased efficiency, fit-for-purpose solutions, and greater transparency with data sharing to enable meaningful actions. Digitalization will figure largely in this transition, enabling data integration for measuring, managing, verifying, and communicating actions as well as for...

This edition of the Oil and Gas (O&G) TOE features information about the conversion of natural gas into high-quality liquid derivatives using gas-to-liquid (GTL) technology. The TOE also covers the innovations in drone technology for monitoring midstream and upstream assets. The TOE focuses on real-time data management technologies to enhance drill...

In May and June 2023, Frost & Sullivan conducted a global survey of network decision makers to understand businesses perceptions and purchase decisions regarding SD-WAN and SASE. This report examines responses from APAC businesses of various sizes in verticals including financial services, healthcare, retail, education, government, technology, and...

03 Oct 2022  |  Global  |  Technology Research

No Code: The Future of Software Development Process

No-code Platforms Will Disrupt the Way Enterprises Develop Their Applications.

Infographics

×

As enterprises emerge from the COVID-19 pandemic, many are still struggling to completely resume operations, such as streamlining workflows, improving employee productivity, and enhancing customer experience, in an operating environment that is vastly different from what it was 2 years ago. Enterprises’ teams are more geographically dispersed than ...

The used premium car sector represents almost 3% of the Mexican used car market; it expanded in the last few years due to global scarcity of materials and auto parts, an absence of new premium vehicles, and increasing prices. In Mexico, most used premium vehicle local transactions are informal due to pricing offered to clients and less bureaucr...

13 Aug 2018  |  North America  |  Market Research

Global Diagnostic Neuroimaging Markets and Emerging Applications, Forecast to 2022

Headways in Neuroimaging Continues to Play a Promising Care Pathway in Diagnosis and Treatment of Major Neurological Disorders

Infographics

×

Key Issues Addressed Key Benefits

The scope of this research study covers the diagnostic applications of advanced imaging in neurological and neurodegenerative disorders. The geographical market covered is North America (US), Europe, and Asia-Pacific (APAC).--BEGIN PROMO--Key Features This research service provides the following metrics: A quantification of the size of procedur...

23 Sep 2020  |  Global  |  Market Research

Disruptive Technologies with Innovative Business Models Driving Platform and Architecture Strategies for AVs, 2020

Growth Potential Enhanced by 4-layered Platform Approach Toward CASE

Infographics

×

Key Issues Addressed

The automotive industry is at a tipping point, with traditional business models being disrupted, changing the market dynamicsincreasing urbanization and congestion, tighter emission and safety regulations, evolving consumer expectations for digital features, and focus on user safety. The ecosystem is evolving at a rapid pace, not only through the ...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...